iti-214-phosphate

Description: ITI-214 is an orally bioavailable, potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases. ITI-214 exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families, and showed good efficacy in vivo. Currently, this investigational new drug is in Phase I clinical development and being considered for the treatment of several indications including cognitive deficits associated with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other CNS and non-CNS disorders. References: Li P, Zheng H, Zhao J, Zhang L, Yao W, Zhu H, Beard JD, Ida K, Lane W, SnellG, Sogabe S, Heyser CJ, Snyder GL, Hendrick JP, Vanover KE, Davis RE, WennogleLP. Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for theTreatment of Cognitive Impairment Associated with Neurodegenerative andNeuropsychiatric Diseases. J Med Chem. 2016 Jan 20. Epub ahead of print PubMedPMID: 26789933.